Charles River Laboratories | CRL - Current Liabilities

Stock Price
201.41
Daily Change
-11.81 -5.54%
Monthly
-3.32%
Yearly
23.47%
Q1 Forecast
204.00

Charles River Laboratories reported $1.12B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Agilent USD 2.35B 455M Sep/2025
Align Technology USD 1.97B 29.02M Sep/2025
Bio-Rad Laboratories USD 522.3M 26.6M Sep/2025
Bruker USD 1.27B 79.3M Sep/2025
Cardinal Health USD 40.27B 1.37B Sep/2025
Charles River Laboratories USD 1.12B 41.45M Sep/2025
Cigna USD 56.45B 326M Sep/2025
CVS Health USD 92.7B 1.47B Sep/2025
Danaher USD 6.81B 483M Dec/2025
Dentsply International USD 1.4B 239M Sep/2025
Elevance Health USD 41.04B 157M Dec/2025
Galapagos EUR 366.56M 36.39M Sep/2025
Hologic USD 951.3M 25.9M Dec/2025
Humana USD 16.18B 1.04B Sep/2025
Illumina USD 1.96B 501M Sep/2025
Incyte USD 1.34B 60.11M Sep/2025
IQVIA Holdings USD 8.51B 936M Sep/2025
Laboratory Of America USD 2.63B 87.6M Sep/2025
Lonza CHF 3.58B 970M Dec/2024
McKesson USD 68.03B 3.7B Sep/2025
Merck EUR 8.64B 1.22B Sep/2025
Mettler Toledo International USD 1.19B 85.24M Sep/2025
Novartis USD 32B 286M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Quest Diagnostics USD 2.13B 110M Sep/2025
Revvity USD 1.22B 550.93M Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
United Therapeutics USD 546.3M 19.2M Sep/2025
UnitedHealth USD 115.53B 4.74B Sep/2025
Waters USD 1.25B 235.17M Sep/2025
West Pharmaceutical Services USD 635.4M 30.8M Sep/2025